经皮球囊压迫术中心动过缓是否可作为三叉神经痛预后指标
本研究为单中心观察性研究,纳入123例接受经皮球囊压迫术的三叉神经痛患者,其中心动过缓组35例、心率正常组88例。结果显示心动过缓组获得优良结局(BNI I-II)的比例为45%,正常组为34%(P=0.05),且心动过缓组无痛生存期显著更长(26个月 vs 13个月,P=0.017)。结论认为术中心动过缓可能提示更好的临床疗效,可作为预后因素。
要点
- 经皮球囊压迫术中出现心动过缓与更好的疼痛结局和更长无痛生存期相关。
- 心动过缓组优良结局比例为45%,正常组为34%,差异处于统计学边缘(P=0.05)。
- 心动过缓组平均无痛生存期26个月,显著长于正常组的13个月(P=0.017)。
核心结论
- 经皮球囊压迫术中出现心动过缓的患者临床疗效更优,疼痛结局和无痛生存期均优于心率正常组。
- 该现象可作为独立的临床预后因素,与获得梨形球囊和压迫时间无关。
研究设计与样本
- 单中心神经外科单元的观察性研究。
- 纳入123例接受经皮球囊压迫术治疗的三叉神经痛患者,分为心动过缓组(n=35)和心率正常组(n=88)。
主要发现
- 心动过缓组优良结局(BNI I-II)比例为45%,心率正常组为34%(P=0.05)。
- 心动过缓组平均无痛生存期为26个月,显著长于心率正常组的13个月(P=0.017)。
- 心动过缓组在整个随访期内疼痛缓解疗效稳定。
关键数值与推荐
- 优良结局定义为BNI I-II级。
- 心动过缓组优良结局45%,心率正常组34%(P=0.05)。
- 平均无痛生存期心动过缓组26个月,心率正常组13个月(P=0.017)。
临床怎么用
- 术中出现心动过缓可视为球囊有效压迫Gasser神经节的标志,提示可能获得更好疗效。
- 心动过缓可作为预后参考指标,但需注意其与压迫时间及获得梨形球囊无关。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trigeminal ganglion percutaneous balloon compression (PBC) for treating trigeminal neuralgia (TN) is favored for its high success rate and minimal complications. During PBC, significant hemodynamic changes can occur, leading to sudden bradycardia, asystole, or rapid blood pressure increase, collectively known as the trigeminocardiac reflex (TCR). Isolated bradycardia during PBC is common. Despite this, mortality risk is very low, with bradycardia becoming critical in few patients. This unknown mechanism might indicate effective compression on Gasser's ganglion, crucial for clinical response in treating TN. METHODS: An observational study of TN patients who underwent PBC was performed at a neurosurgical unit. The outcome was to assess prognostic impact of bradycardia during PBC and investigate clinical factors for its occurrence. RESULTS: A total of 123 patients were included, divided into 2 groups: the bradycardia group (n = 35) and the normal frequency group (n = 88). An excellent outcome (BNI I-II) was achieved in 45% of patients in Group 1 and in 34% of patients in Group 2 (P = 0.05). The mean pain-free survival (PFS) duration was significantly longer in the bradycardia group (26 vs. 13 months, P = 0.017). Stable efficacy of pain relief was found in the bradycardia group throughout the follow-up period. CONCLUSION: Patients who manifested bradycardia demonstrated greater clinical efficacy with a superior Pain outcome and PFS compared with the normal-frequency group with an independent clinical outcome with respect to obtaining pear-shape and time of compression. This finding could be considered as an important prognostic factor.
引用
- Armocida D, Fronda C, Rizzi L, et al. Is the Occurrence of Bradycardia During Percutaneous Balloon Compression for Trigeminal Neuralgia a Clinical Prognostic Indicator? World Neurosurg. 2026. PMID: 42069213. doi:10.1016/j.wneu.2026.125019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。